The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Cisplatin Ototoxicity and Protection: Clinical and Experimental Studies
Open accessAbstract
Cisplatin is a chemotherapeutic agent that is widely used to treat a variety of malignant tumors. Serious dose-limiting side effects like ototoxicity, nephrotoxicity and neurotoxicity occur with the use of this agent. This review summarizes recent important clinical and experimental investigations of cisplatin ototoxicity. It also discusses the utility of protective agents employed in patients and in experimental animals. The future strategies for limiting cisplatin ototoxicity will need to avoid interference with the therapeutic effect of cisplatin in order to enhance the quality of life of patients receiving this important anti-tumor agent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular mechanism of nucleotide excision repair
de Laat, W. L., Jaspers, N. G. J., & Hoeijmakers, J. H. J. (1999) · Genes & Development · doi:10.1101/gad.13.7.768 · Cited by 1,122 · cited 2×
“The NER identifies lesions made by two pathways: 1) The global genome-NER (GGNER) identifies DNA damage on non-transcribed genes (de Laat et al. 1999, Costa et al. 2003), and is via activation of xeroderma pigmentosum complementation group C (XPC) and it’s conjugates (Boonstra et al. 2001, Chen et…”
BackgroundPigeolet, E., Corbisier, P., Houbion, A., Lambert, D., Michiels, C., Raes, M., Zachary, M.-D., & Remacle, J. (1990) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(90)90078-t · Cited by 740
Mechanisms of cisplatin-induced ototoxicity and prevention
Rybak, L. P., Whitworth, C. A., Mukherjea, D., & Ramkumar, V. (2007) · Hearing Research · doi:10.1016/j.heares.2006.09.015 · Cited by 563
Self-citationKnight, K. R. G., Kraemer, D. F., & Neuwelt, E. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.5355 · Cited by 542
Nox3, a superoxide-generating nadph oxidase of the inner ear
Bánfi, B., Malgrange, B., Knisz, J., Steger, K., Dubois-Dauphin, M., & Krause, K.-H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403046200 · Cited by 467 · cited 11×
“A major source of ROS which has been identified in the cochlea is an isoform of NADPH oxidase, NOX3 (Bánfi et al. 2004).”
BackgroundInfluentialIntracellular K+ Suppresses the Activation of Apoptosis in Lymphocytes
Hughes, F. M., Bortner, C. D., Purdy, G. D., & Cidlowski, J. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30567 · Cited by 460
The eukaryotic nucleotide excision repair pathway
Costa, R. (2003) · Biochimie · doi:10.1016/j.biochi.2003.10.017 · Cited by 373
Clinical Perspectives on Platinum Resistance
Giaccone, G. (2000) · Drugs · doi:10.2165/00003495-200059004-00002 · Cited by 364
Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose
Li, Y., Womer, R. B., & Silber, J. H. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.08.009 · Cited by 358
Samimi, G., Safaei, R., Katano, K., Holzer, A. K., Rochdi, M., Tomioka, M., Goodman, M., & Howell, S. B. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0137 · Cited by 358
Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer
Bokemeyer, C., Berger, C., Hartmann, J., Kollmannsberger, C., Schmoll, H., Kuczyk, M., & Kanz, L. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.226 · Cited by 339
Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance.
Komatsu, M., Sumizawa, T., Mutoh, M., Chen, Z., Terada, K., Furukawa, T., Yang, X., Gao, H., Miura, N., Sugiyama, T., et al. (2000) · PubMed · Cited by 328
Selvakumaran, M., Pisarcik, D., Bao, R., Yeung, A. T., & Hamilton, T. C. (2003) · PubMed · Cited by 317
Bertolini, P., Lassalle, M., Mercier, G., Raquin, M. A., Izzi, G., Corradini, N., & Hartmann, O. (2004) · Journal of Pediatric Hematology/Oncology · doi:10.1097/01.mph.0000141348.62532.73 · Cited by 305
The roles of copper transporters in cisplatin resistance
Kuo, M. T., Chen, H. H. W., Song, I.-S., Savaraj, N., & Ishikawa, T. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9045-3 · Cited by 283
Increased nucleotide excision repair in cisplatin-resistant ovarian cancer cells
Ferry, K. V., Hamilton, T. C., & Johnson, S. W. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00441-x · Cited by 275
Kopke, R. D., Liu, W., Gabaizadeh, R., Jacono, A., Feghali, J. G., Spray, D. C., Garcia, P., Steinman, H., Malgrange, B., Ruben, R. J., et al. (1997) · PubMed · Cited by 266
Self-citationHuang, E., Teh, B. S., Strother, D. R., Davis, Q. G., Chiu, J. K., Lu, H. H., Carpenter, L. S., Mai, W.-Y., Chintagumpala, M. M., South, M., et al. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)02641-4 · Cited by 261
A necessary role for cell shrinkage in apoptosis
Bortner, C. D., & Cidlowski, J. A. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00225-1 · Cited by 260
SEVERE NEUROTOXICITY, OTOTOXICITY AND NEPHROTOXICITY FOLLOWING HIGH-DOSE CISPLATIN AND AMIFOSTINE
Sastry, J., & Kellie, S. J. (2005) · Pediatric Hematology and Oncology · doi:10.1080/08880010590964381 · Cited by 258
d-Methionine provides excellent protection from cisplatin ototoxicity in the rat
Campbell, K. C. M., Rybak, L. P., Meech, R. P., & Hughes, L. (1996) · Hearing Research · doi:10.1016/s0378-5955(96)00152-9 · Cited by 240
Self-citationSo, H., Kim, H., Lee, J.-H., Park, C., Kim, Y., Kim, E., Kim, J.-K., Yun, K.-J., Lee, K.-M., Lee, H.-Y., et al. (2007) · Journal of the Association for Research in Otolaryngology · doi:10.1007/s10162-007-0084-9 · Cited by 230
Wang, J., Ladrech, S., Pujol, R., Brabet, P., Van De Water, T. R., & Puel, J.-L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1581 · Cited by 203
Effect of protective agents against cisplatin ototoxicity.
Rybak, L. P., Husain, K. M., Morris, C., Whitworth, C. A., & Somani, S. M. (2000) · PubMed · Cited by 200
Self-citationOldenburg, J., Kraggerud, S. M., Cvancarova, M., Lothe, R. A., & Fossa, S. D. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.9599 · Cited by 197
Townsend, P. A., Scarabelli, T. M., Pasini, E., Gitti, G., Menegazzi, M., Suzuki, H., Knight, R. A., Latchman, D. S., & Stephanou, A. (2004) · The FASEB Journal · doi:10.1096/fj.04-1716fje · Cited by 178
Stephanou, A., Scarabelli, T. M., Brar, B. K., Nakanishi, Y., Matsumura, M., Knight, R. A., & Latchman, D. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101177200 · Cited by 173
Application of Antioxidants and Other Agents to Prevent Cisplatin Ototoxicity
Rybak, L. P., Whitworth, C., & Somani, S. (1999) · The Laryngoscope · doi:10.1097/00005537-199911000-00003 · Cited by 169
Self-citationDirect effects of reactive oxygen species on cochlear outer hair cell shape in vitro
Clerici, W. J., DiMartino, D. L., & Prasad, M. R. (1995) · Hearing Research · doi:10.1016/0378-5955(95)00010-2 · Cited by 164
Zheng, J. L., & Gao, W. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01333.x · Cited by 157
Zhang, M., Liu, W., Ding, D., & Salvi, R. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00286-0 · Cited by 157
Fouladi, M., Chintagumpala, M., Ashley, D. M., Kellie, S. J., Gururangan, S., Hassall, T., Gronewold, L., Stewart, C. F., Wallace, D., Broniscer, A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.3974 · Cited by 149
Cisplatin Ototoxicity: Involvement of Iron and Enhanced Formation of Superoxide Anion Radicals
Dehne, N., Lautermann, J., Petrat, F. M., Rauen, U., & de GROOT, H. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9171 · Cited by 148
Mukherjea, D., Jajoo, S., Whitworth, C. A., Bunch, J. R., Turner, J. G., Rybak, L. P., & Ramkumar, V. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1307-08.2008 · Cited by 147
Self-citationCaronia, D., Patiño‐García, A., Milne, R. L., Zalacaín, M., Pita, G., Alonso, M. R., Moreno, L. T., Sierrasesúmaga-Ariznabarreta, L., Benitez, J. J., & González‐Neira, A. (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2009.19 · Cited by 144
Cisplatin-Induced Ototoxicity: Effect of Intratympanic Dexamethasone Injections
Hill, G. W., Morest, D. K., & Parham, K. (2008) · Otology & Neurotology · doi:10.1097/mao.0b013e31818599d5 · Cited by 143
So, H., Kim, H., Kim, Y., Kim, E., Pae, H., Chung, H., Kim, H. J., Kwon, K., Lee, K., Lee, H.-Y., et al. (2008) · Journal of the Association for Research in Otolaryngology · doi:10.1007/s10162-008-0126-y · Cited by 130
Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model
Dickey, D. T., Muldoon, L. L., Kraemer, D. F., & Neuwelt, E. A. (2004) · Hearing Research · doi:10.1016/j.heares.2004.02.007 · Cited by 130
Hitchcock, Y. J., Tward, J. D., Szabó, A., Bentz, B. G., & Shrieve, D. C. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.05.040 · Cited by 128
Megalin genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin
Riedemann, L., Lanvers, C., Deuster, D., Peters, U., Boos, J., Jürgens, H., & Zehnhoff‐Dinnesen, A. A. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500455 · Cited by 119
Direct effects of intraperilymphatic reactive oxygen species generation on cochlear function
Clerici, W. J., & Yang, L. (1996) · Hearing Research · doi:10.1016/s0378-5955(96)00126-8 · Cited by 111
Campbell, K. C. M., Meech, R. P., Rybak, L. P., et al. (2003) · Journal of the American Academy of Audiology · doi:10.1055/s-0040-1715719 · Cited by 108
Self-citationMarina, N. M., Chang, K. W., Malogolowkin, M. H., London, W. B., Frazier, A. L., Womer, R. B., Rescorla, F. J., Billmire, D. F., Davis, M. M., Perlman, E. J., et al. (2005) · Cancer · doi:10.1002/cncr.21218 · Cited by 104
Future opportunities in preventing cisplatin induced ototoxicity
van den Berg, J. H., Beijnen, J. H., Balm, A. J. M., & Schellens, J. H. M. (2006) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.04.011 · Cited by 101
Cisplatin-Induced Hair Cell Death Requires STAT1 and Is Attenuated by Epigallocatechin Gallate
Schmitt, N. C., Rubel, E. W., & Nathanson, N. M. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5842-08.2009 · Cited by 101
The protective effect of intratympanic dexamethasone on cisplatin‐induced ototoxicity in guinea pigs
Daldal, A., Odabaşı, O., & Şerbetçioğlu, B. (2007) · Otolaryngology · doi:10.1016/j.otohns.2007.05.068 · Cited by 99
Zuur, C. L., Simis, Y. J. W., Lansdaal, P. E., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.01.042 · Cited by 93
Tornaletti, S., Patrick, S. M., Turchi, J. J., & Hanawalt, P. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305394200 · Cited by 91
So, H.-S., Kim, H.-J., Lee, J.-H., Lee, J.-H., Sy, P., Park, C., Kim, Y.-H., Jk, K., Lee, K.-M., Kim, K.-S., et al. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401863 · Cited by 89
Lee, J. E., Nakagawa, T., Kim, T. S., Endo, T., Shiga, A., Iguchi, F., Lee, S. H., & Ito, J. (2004) · Acta Oto-Laryngologica · doi:10.1080/00016480410017521 · Cited by 87
Expression of the kidney injury molecule 1 in the rat cochlea and induction by cisplatin
Mukherjea, D., Whitworth, C. A., Nandish, S., Dunaway, G., Rybak, L. P., & Ramkumar, V. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.12.044 · Cited by 83
Self-citationChen, X., Frisina, R. D., Bowers, W. J., Frisina, R. D., & Federoff, H. J. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0334 · Cited by 80
So, H., Park, C., Kim, H., Lee, J.-H., Park, S.-Y., Lee, J.-H., Lee, Z.-W., Kim, H.-M., Kalinec, F., LIM, D. J., et al. (2005) · Hearing Research · doi:10.1016/j.heares.2005.01.011 · Cited by 72
AAV-Mediated Delivery of the Caspase Inhibitor XIAP Protects Against Cisplatin Ototoxicity
Cooper, L. B., Chan, D. K., Roediger, F. C., Shaffer, B. R., Fraser, J. F., Musatov, S. A., Selesnick, S. H., & Kaplitt, M. G. (2006) · Otology & Neurotology · doi:10.1097/01.mao.0000202647.19355.6a · Cited by 71
Ikeda, K., Sunose, H., & Takasaka, T. (1993) · Acta Oto-Laryngologica · doi:10.3109/00016489309135781 · Cited by 67
Protein Kinase Cδ Regulates Apoptosis via Activation of STAT1
DeVries, T. A., Kalkofen, R. L., Matassa, A. A., & Reyland, M. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407448200 · Cited by 66
Transtympanic perfusion: indications and limitations
Light, J. P., & Silverstein, H. (2004) · Current Opinion in Otolaryngology & Head & Neck Surgery · doi:10.1097/01.moo.0000134438.91734.38 · Cited by 64
Mechanisms of Apoptosis Induced by Cisplatin in Marginal Cells in Mouse Stria Vascularis
Lee, J., Nakagawa, T., Kita, T., Kim, T. S., Iguchi, F., Endo, T., Shiga, A., Lee, S. H., & Ito, J. (2004) · ORL · doi:10.1159/000079329 · Cited by 64
Up-regulation of adenosine receptors in the cochlea by cisplatin
Ford, M. S., Nie, Z., Whitworth, C. A., Rybak, L. P., & Ramkumar, V. (1997) · Hearing Research · doi:10.1016/s0378-5955(97)00103-2 · Cited by 62
Self-citationLiang, F., Schulte, B. A., Qu, C., Hu, W. M., & Shen, Z. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.05.055 · Cited by 61
Cisplatin ototoxicity and otoprotection with sodium salicylate
Hyppolito, M. Â., de Oliveira, J. A. A., & Rossato, M. (2006) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-006-0070-6 · Cited by 60
Protection against cisplatin ototoxicity by adenosine agonists
Whitworth, C. A., Ramkumar, V., Jones, B., Tsukasaki, N., & Rybak, L. P. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.01.010 · Cited by 59
Self-citationPeters, U., Preisler-Adams, S., Lanvers‐Kaminsky, C., Jürgens, H., & Lamprecht-Dinnesen, A. (2003) · PubMed · Cited by 58
Church, M. W., Blakley, B. W., Burgio, D. L., & Gupta, A. K. (2004) · Journal of the Association for Research in Otolaryngology · doi:10.1007/s10162-004-4011-z · Cited by 57
NF-κB is Required for Survival of Immature Auditory Hair Cells In Vitro
Nagy, I., Monge, A., Albinger‐Hegyi, A., Schmid, S., & Bodmer, D. (2005) · Journal of the Association for Research in Otolaryngology · doi:10.1007/s10162-005-0006-7 · Cited by 45
Pierre, P. V., Laurell, G. F. E., Wallin, I., & Ehrsson, H. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623101009 · Cited by 43
Defining the function of XPC protein in psoralen and cisplatin-mediated DNA repair and mutagenesis
Chen, Z. B., Xu, X. S., Yang, J., & Wang, G. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg051 · Cited by 43
Zykova, T. A. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh334 · Cited by 42
Chan, D. K., Lieberman, D. M., Musatov, S. A., Goldfein, J., Selesnick, S. H., & Kaplitt, M. G. (2007) · Otology & Neurotology · doi:10.1097/01.mao.0000247826.28893.7a · Cited by 39
Proapoptotic effects of NF-κB on cisplatin-induced cell death in auditory cell line
Chung, W., Boo, S. H., Chung, M. K., Lee, H.-S., Cho, Y., & Hong, S. H. (2008) · Acta Oto-Laryngologica · doi:10.1080/00016480701881811 · Cited by 36
Differential Ultraviolet-B-Induced Immunomodulation in XPA, XPC, and CSB DNA Repair-Deficient Mice
Boonstra, A., van Oudenaren, A., Baert, M. R. M., Leenen, P. J. M., Savelkoul, H. F. J., STEEG, H. V., van der Horst, G. T. J., Hoeijmakers, J. H. J., & Garssen, J. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01390.x · Cited by 36
Guthrie, O. W., Li‐Korotky, H., Durrant, J. D., & Balaban, C. D. (2008) · Hearing Research · doi:10.1016/j.heares.2008.01.013 · Cited by 36
Cited by
The side effects of platinum-based chemotherapy drugs: a review for chemists
Oun, R., Moussa, Y. E., & Wheate, N. J. (2018) · Dalton Transactions · doi:10.1039/c8dt00838h · Cited by 1,737
Ma, P., Xiao, H., Yu, C., Liu, J., Cheng, Z., Song, H., Zhang, X., Li, C., Wang, J., Gu, Z., et al. (2017) · Nano Letters · doi:10.1021/acs.nanolett.6b04269 · Cited by 649
An integrated view of cisplatin-induced nephrotoxicity and ototoxicity
Karasawa, T., & Steyger, P. S. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.06.012 · Cited by 475
Copper metabolism as a unique vulnerability in cancer
Shanbhag, V. C., Gudekar, N., Jasmer, K., Papageorgiou, C., Singh, K., & Petris, M. J. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118893 · Cited by 368
McSweeney, K. R., Gadanec, L. K., Qaradakhi, T., Ali, B. A., Zulli, A., & Apostolopoulos, V. (2021) · Cancers · doi:10.3390/cancers13071572 · Cited by 363
Metadata
- Authors
- Rybak, L. P., Mukherjea, D., Jajoo, S., & Ramkumar, V.
- Venue
- The Tohoku Journal of Experimental Medicine
- Publisher
- Tohoku University Medical Press
- Published
- 2009
- Volume
- 219
- Issue
- 3
- Pages
- 177-186
- ISSN
- 0040-8727 (ISSN-L)
- 1349-3329
- OpenAlex
- W2082313150
- Cited by
- 372
- References
- 72
- FWCI
- 9.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.